Tentech Inc. launches ‘REGEVAN PN’ an Injectable Product Based on Polynucleotides (PN) Ingredient.

 Tentech Inc. launches ‘REGEVAN PN’ an Injectable Product Based on Polynucleotides (PN) Ingredient.

Tentech Inc. has announced on Tuesday the release of ‘REGEVAN PN’ for the second time in South Korea. REGEVAN ingredient is based on Polynucleotides (PN).

The main use of REGEVAN PN is to temporarily improve facial wrinkles on adults. REHEVAN PN, on sterilization of single-use medical device, is packed with 2 syringes(1ML) per box.

Polynucleotide, is obtained from the extracts of DNA components from the sperm of Salmon or trout, can be divided between PN and PDRN. PN, is typically used for medical devices, while PDRN is typically used for the raw materials of medicines.

Tentech Inc.’s official said, “To expand rapidly domestic market share, we will start various marketing activities.”

Meanwhile, since the release of REGEVAN PN in South Korea, REGEBVAN PN has surpassed over 10,000 domestic unit sales within two weeks according to Tentech Inc. (updated)

Exit mobile version